Lv4
520 积分 2023-07-09 加入
Risk-Reducing Bilateral Mastectomy and Mortality in Carriers of BRCA1 and BRCA2 Variants
1个月前
已关闭
Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk
1个月前
已完结
Diagnosis and Management of High-Risk Breast Lesions
1个月前
已完结
Management of Women With Breast Cancer and Pathogenic Variants in Genes Other Than BRCA1 or BRCA2
1个月前
已完结
Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation
1个月前
已完结
Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer
1个月前
已完结
Survival Outcomes With or Without Risk-Reducing Mastectomy in BRCA1 and BRCA2 Pathogenic Variant Carriers
1个月前
已关闭
Risk-Reducing Bilateral Mastectomy and Mortality in Carriers of BRCA1 and BRCA2 Variants
1个月前
已关闭
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecan
2个月前
已完结
Bilateral Mastectomy and Breast Cancer Mortality
2个月前
已完结
皖公网安备34019202002308
